Clinical trials of Kushtadi Churna Vati in Diabetes.

Randomized controlled trial of Kushtadi Churna Vati as an add-on effect in the management of Madhumeha

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017351

Enrollment

Registered

2019-01-31

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Kushtadi churna Vati: 500 mg T.D.S. orally With luke warm water pragbhakt time, total duration 3 months Control Intervention1: continue OHA: continue conventional anti diabetic drugs in

Eligibility

Inclusion criteria

Inclusion criteria: 1. A known Diabetic on treatmenet and a newly diagnosed Diabetes. 2. Patient with fasting blood sugar upto 220mg% and post prandial blood sugar upto 300mg% 3.patient having HBA1C upto 10 4.Patient having fasting blood sugar in between 221 to 250 and post prandial 301 ton 350 will be included , if HBA1C is upto 10. 5. If the patient is taking ayurvedic medicine for Madhumeha , washing period for them will be 8 days.

Exclusion criteria

Exclusion criteria: 1. Patients with fasting blood sugar above 220 mg% and post prandial blood sugar above 300mg%. 2. Patient who is already taking Ayurvedic management for Madhumeha. 3. Diabetes Mellitus Type-I ,Acromegaly, CushingÃ¢â?¬•s syndrome and pancreatic disorder. 4. Those who are under Insulin therapy. 5. Pregnant and lactating mothers. 6. Patients with acute complications like Hyperglycemic coma, Ketoacidosis and infections like gangrene. 7. Patients with K/C/O Nephropathy, Neuropathy and Retinopathy. 8. Patients with gastrointestinal diseases, Liver diseases, tumors, conditions like cardiovascular disease, acute myocardial infarction, immune-compromised disease(HIV)

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Kushtadi Churna Vati in Madhumeha.Timepoint: 3 months	—

Secondary

Measure	Time frame
1)To evaluate the efficacy of Kushtadi Churna Vati in Madhumeha on the basis of subjective parameters. 2)To evaluate the efficacy of Kushtadi Churna vati in reducing the elevated Blood Sugar Levels in Madhumeha in fasting state. 3) To evaluate the efficacy of Kushtadi Churna Vati in reducing the elevated Blood Sugar Levels in Madhumeha in post prandial state. 4) To evaluate the efficacy of Kushtadi Churna Vati in achieving glycemic control in Madhumeha on the basis of HbA1C.Timepoint: 3 months	—

Measure

Time frame

1)To evaluate the efficacy of Kushtadi Churna Vati in Madhumeha on the basis of subjective parameters. 2)To evaluate the efficacy of Kushtadi Churna vati in reducing the elevated Blood Sugar Levels in Madhumeha in fasting state. 3) To evaluate the efficacy of Kushtadi Churna Vati in reducing the elevated Blood Sugar Levels in Madhumeha in post prandial state. 4) To evaluate the efficacy of Kushtadi Churna Vati in achieving glycemic control in Madhumeha on the basis of HbA1C.Timepoint: 3 months

—

Countries

India

Contacts

Public ContactDr Shweta Lomeshwar Lade

MAM Sumatibhai Shah Ayurved mahavidyalaya Hadapsar Pune

drytk@yahoo.com09423218193

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026